Unique case of oligoastrocytoma with recurrence and grade progression: Exhibiting differential expression of high mobility group-A1 and human telomerase reverse transcriptase.
Mixed gliomas, primarily oligoastrocytomas, account for about 5%-10% of all gliomas. Distinguishing oligoastrocytoma based on histological features alone has limitations in predicting the exact biological behavior, necessitating ancillary markers for greater specificity. In this case report, human telomerase reverse transcriptase (hTERT) and high mobility group-A1 (HMGA1); markers of proliferation and stemness, have been quantitatively analyzed in formalin-fixed paraffin-embedded tissue samples of a 34 years old patient with oligoastrocytoma. Customized florescence-based immunohistochemistry protocol with enhanced sensitivity and specificity is used in the study. The patient presented with a history of generalized seizures and his magnetic resonance imaging scans revealed infiltrative ill-defined mass lesion with calcified foci within the left frontal white matter, suggestive of glioma. He was surgically treated at our center for four consecutive clinical events. Histopathologically, the tumor was identified as oligoastrocytoma-grade II followed by two recurrence events and final progression to grade III. Overall survival of the patient without adjuvant therapy was more than 9 years. Glial fibrillary acidic protein, p53, Ki-67, nuclear atypia index, pre-operative neutrophil-lymphocyte ratio, are the other parameters assessed. Findings suggest that hTERT and HMGA1 are linked to tumor recurrence and progression. Established markers can assist in defining precise histopathological grade in conjuction with conventional markers in clinical setup.
Puneet Gandhi, Richa Khare, Kavita Niraj, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Puneet
P
Gandhi
Puneet Gandhi, Richa Khare, Kavita Niraj, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Richa
R
Khare
Puneet Gandhi, Richa Khare, Kavita Niraj, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Kavita
K
Niraj
Puneet Gandhi, Richa Khare, Kavita Niraj, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Nitin
N
Garg
Puneet Gandhi, Richa Khare, Kavita Niraj, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Sandeep K
SK
Sorte
Puneet Gandhi, Richa Khare, Kavita Niraj, Department of Research, Bhopal Memorial Hospital and Research Centre, Bhopal 462038, India.
Hanni
H
Gulwani
High mobility group-A1; Human telomerase reverse transcriptase; Oligoastrocytoma; Recurrence; Tumor grade
Ai Zheng. 2007 Jun;26(6):601-6
17562265
Int J Clin Exp Pathol. 2014 Dec 01;7(12):8905-10
25674263
Brain Pathol. 2008 Jul;18(3):370-7
18371181
FEBS Lett. 2008 May 28;582(12):1707-10
18435920
Acta Neuropathol. 2007 Aug;114(2):97-109
17618441
Brain Res. 2011 Apr 12;1384:9-14
21300033
Sci Rep. 2013;3:2089
23807566
Acta Neurochir (Wien). 2015 Feb;157(2):179-86
25391974
J Neurooncol. 2012 Feb;106(3):543-9
21984063
Ann Transl Med. 2015 May;3(7):95
26015937